http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20331724

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 854
issn 1387-2877
1875-8908
issueIdentifier 3
pageRange 845-854
publicationName Journal of Alzheimer's disease : JAD
startingPage 845
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bf8a16cc24dd598f53362c68a99d3e5a
bibliographicCitation Devanand DP, Liu X, Chunga RE, Cohen H, Andrews H, Schofield PW, Stern Y, Huey ED, Choi J, Pelton GH. Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment. J Alzheimers Dis. 2020;75(3):845–54. doi: 10.3233/jad-200021. PMID: 32333591.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcd68db1d1826460fc967858021b03f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d119ccffcfb67ce6c1be8ae3f3d02894
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8de52c9ca8782daac917cad772a632c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3654331b028c3561f7f71dbef885c1ec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_112aec694b0e9e13ef6dd5a3ae418f4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1089b2395d03a75209d3c6f45963e7bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b6932f13cca838bfcea7d1431a5e543
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_951fb42bbdec7a6e02183eb711ae8ea8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f554a0e34ade1f9e951747e4abf9395c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b9f0fc89569a99a04520417ebb1a18e
date 2020-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.3233/jad-200021
https://pubmed.ncbi.nlm.nih.gov/32333591
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment
discusses http://id.nlm.nih.gov/mesh/M0004295
http://id.nlm.nih.gov/mesh/M0206795
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D055696Q000187
http://id.nlm.nih.gov/mesh/D002800Q000008
http://id.nlm.nih.gov/mesh/D060825Q000175
http://id.nlm.nih.gov/mesh/D060825Q000188
http://id.nlm.nih.gov/mesh/D000077265Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D060825Q000523
http://id.nlm.nih.gov/mesh/D009483
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D012903Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_efa31556fab5b1efdf7fd0827d809efa
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3152
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_74215c9516abac826539f57c202449f0

Total number of triples: 53.